The acceptance to heterologous booster vaccination of covid-19 vaccine among hcws and targeted population: a cross-sectional study in central china

HIGHLIGHTS

• who: Hong Su from the Jiangsu, China have published the research work: The acceptance to heterologous booster vaccination of COVID-19 vaccine among HCWs and targeted population: A cross-sectional study in central China, in the Journal: (JOURNAL) of 10/05/2022
• what: The most prevalent reason for accepting heterologous booster vaccination among the targeted population was the perception of a higher immune_response (56.9%, Figure 2A), whereas the primary reason for refusing was concern about side effects (61.1%, Figure 2B). This study explored the prevalence and determinant factors of the acceptance of heterologous . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.